Top Pharma Stocks in France
Browse the largest France companies in the world ranked by their Market Capitalization. Global Pharma Companies in France market cap is $165.50B.
18 Oct 2024, 01:18 UTC
Companies: 38
🇫🇷1 |  | $58.19 | 1.25% | 145.93B | 17.98% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇫🇷2 |  | $121.15 | -1.62% | 10.02B | 0.74% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇫🇷3 |  | $429.43 | -0.96% | 3.61B | 7.97% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇫🇷4 |  | $92.81 | 0.97% | 1.10B | -18.46% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇫🇷5 |  | $11.35 | -1.13% | 714.11M | 8.30% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇫🇷6 |  | $36.41 | 0.46% | 632.70M | -17.63% | Underperform S&P500 YTD Benchamark | ⚕️ Healthcare | - |
🇫🇷7 |  | $0.50 | 1.10% | 486.96M | 8721.57% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇫🇷8 |  | $18.21 | 0.49% | 458.58M | 124.38% | Outperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇫🇷9 |  | $4.75 | 2.69% | 451.47M | -25.55% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇫🇷10 |  | $2.98 | -0.07% | 414.03M | -42.28% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇫🇷11 |  | $5.27 | 6.38% | 248.10M | -29.49% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇫🇷12 |  | $4.39 | 1.67% | 218.79M | 10.64% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇫🇷13 |  | $1.06 | 4.40% | 197.64M | 128.37% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇫🇷14 |  | $2.28 | 1.23% | 183.71M | -22.05% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇫🇷15 |  | $8.48 | 1.73% | 183.08M | 78.27% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇫🇷16 |  | $2.31 | -0.72% | 165.14M | -25.95% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇫🇷17 |  | $23,792.58 | 0.00% | 120.01M | -14.40% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇫🇷18 |  | $1.15 | 0.00% | 116.35M | -24.89% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇫🇷19 |  | $2.20 | -4.02% | 113.78M | -51.66% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇫🇷20 |  | $7.94 | -2.19% | 91.86M | 2.29% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇫🇷21 |  | $6.32 | 0.35% | 88.76M | -51.70% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇫🇷22 |  | $0.80 | -1.50% | 76.97M | -62.03% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇫🇷23 |  | $5.61 | -1.94% | 73.59M | -61.45% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇫🇷24 |  | $1.15 | 0.39% | 57.15M | -71.09% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇫🇷25 |  | $1.37 | -0.65% | 44.09M | -5.08% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇫🇷26 |  | $4.08 | -0.27% | 33.44M | -20.22% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇫🇷27 |  | $1.47 | -0.15% | 23.17M | -74.42% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇫🇷28 |  | $0.61 | 3.96% | 22.14M | 1.10% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇫🇷29 |  | $1.13 | 3.03% | 18.81M | -45.16% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇫🇷30 |  | $16.57 | 6.43% | 18.00M | 75.29% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇫🇷31 |  | $1.16 | 0.19% | 14.23M | -60.53% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇫🇷32 |  | $0.09 | 1.40% | 13.65M | -50.80% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇫🇷33 |  | $0.24 | 33.02% | 11.80M | -49.76% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇫🇷34 |  | $1.85 | 0.36% | 11.25M | -64.55% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇫🇷35 |  | $0.44 | 14.29% | 5.84M | -86.44% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇫🇷36 |  | $0.66 | 0.68% | 5.11M | -47.43% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇫🇷37 |  | $0.62 | 0.00% | 3.09M | -34.88% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇫🇷38 |  | $0.00 | 0.00% | 2.35M | 200.00% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
